Find trials
Consejos para buscar

A Study to See if Brief Education Specific to Smoking and Chronic Pain Will Encourage Participation in Smoking Abstinence Therapy

Overview

Información sobre este estudio

The purpose of this study is to determine if a brief educational intervention about the connections between smoking and chronic pain will promote the participation in a smoking abstinence therapy program among smokers seeking treatment for chronic pain.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria

  • Age greater than 18 years.
  • Chronic pain greater than 3 months duration
  • Smoke at least 10 cigarettes daily                                            

 

Exclusion Criteria

  • Cancer-related pain
  • History of schizophrenia or other chronic psychotic disorder
  • History of a dementing illness
  • Use of other forms of tobacco including pipe, cigar, or chewing.
  • Current participation in a smoking abstinence program

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus

Rochester, Minn.

Investigador principal de Mayo Clinic

William Hooten, M.D.

Cerrado para la inscripción

More information

Publicaciones

  • Current evidence suggests it may be difficult for patients with chronic pain to quit smoking and, based on previous formative work, a 7-session individual and group-based cognitive behavioral (CB) intervention was developed. The primary aim of this randomized controlled pilot trial was to test the hypothesis that abstinence at month 6 would be greater among patients with chronic pain who received the CB intervention compared to a control condition. Upon admission to a 3-week interdisciplinary pain treatment (IPT) program, patients were randomized to receive the CB intervention (n=30) or the control condition (n=30). The 7-day point prevalence of self-reported smoking status was assessed at week 3 (upon completion of the 3-week IPT program) and at month 6 in an intent-to-treat analysis. At week 3, 30% (n=9) of patients in the CB condition were abstinent from smoking compared to 10% (n=3) in the control group (P=.104). At month 6, 20% (n=6) of patients who received the CB intervention were abstinent compared to none in the control group (P=.024). At week 3, a significant group by time interaction effect was found where the CB patients experienced greater improvements in self-efficacy from baseline compared to the control group (P=.002). A greater proportion of patients randomized to the CB group completed the IPT program (P=.052). The findings of this pilot trial suggest that integration of a CB-based smoking abstinence intervention into ongoing pain therapy may be an effective treatment for smokers with chronic pain. Read More on PubMed

Otros temas en investigación

.
CLS-20301648

Mayo Clinic Footer